FIDELIS iM’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$451K Buy
1,705
+6
+0.4% +$1.58K 0.15% 23
2026
Q2
$431K Buy
1,699
+8
+0.5% +$1.86K 0.15% 20
2026
Q1
$413K Buy
1,691
+302
+22% +$70.3K 0.16% 20
2025
Q4
$288K Sell
1,389
-634
-31% -$125K 0.11% 22
2025
Q3
$327K Buy
+2,023
New +$347K 0.2% 18
2025
Q2
– Sell
-1,261
Closed -$209K – 24
2025
Q1
$209K Buy
+1,261
New +$197K 0.1% 22
2024
Q4
– Sell
-1,272
Closed -$206K – 22
2024
Q3
$206K Buy
+1,272
New +$203K 0.09% 22
2024
Q2
– Sell
-1,279
Closed -$202K – 19
2024
Q1
$202K Buy
+1,279
New +$204K 0.1% 18
2023
Q3
– Sell
-1,252
Closed -$207K – 18
2023
Q2
$207K Buy
+1,252
New +$202K 0.12% 19
2023
Q1
– Sell
-2,117
Closed -$374K – 19
2022
Q4
$374K Buy
2,117
+64
+3% +$11.1K 0.24% 18
2022
Q3
$335K Buy
2,053
+8
+0.4% +$1.35K 0.23% 18
2022
Q2
$363K Buy
2,045
+7
+0.3% +$1.25K 0.24% 20
2022
Q1
$361K Buy
2,038
+8
+0.4% +$1.36K 0.21% 20
2021
Q4
$347K Buy
2,030
+7
+0.3% +$1.15K 0.2% 18
2021
Q3
$327K Buy
+2,023
New +$345K 0.2% 18

Other funds holding JNJ

FIDELIS iM's JNJ Position: Q3 2026 in Review

FIDELIS iM increased its Johnson & Johnson (JNJ) stake by 0.35% in Q3 2026, buying an estimated $1.58K and bringing the position to 1,705 shares worth $451K. The position accounts for 0.15% of the portfolio, ranked #23.

FIDELIS iM first reported a position in JNJ in Q3 2021 and has held it in 15 quarters since. 1,611 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • FIDELIS iM held 1,705 shares of Johnson & Johnson worth $451K as of Q3 2026.
  • FIDELIS iM bought 6 Johnson & Johnson shares in Q3 2026, an estimated $1.58K.
  • Johnson & Johnson made up 0.15% of FIDELIS iM's portfolio in Q3 2026, its #23 holding.
  • FIDELIS iM first reported a position in Johnson & Johnson in Q3 2021 and has held it in 15 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on FIDELIS iM's 13F filing for Q3 2026, filed 16 Oct 2026.